Fierce Pharma July 11, 2024
CDMO Tergus Pharma plans to merge with MedPharm, a U.K.-based company that specializes in the development of dermatology, mucosal membrane and other products.
The move will boost the combined firm’s global position in topical and transdermal pharmaceuticals, the companies said in a joint press release.
Tergus, which is based in Durham, North Carolina, is a portfolio company of Great Point Partners. MedPharm falls under the umbrella of Ampersand Capital Partners.
Financial details of the deal weren’t disclosed.
Going forward, the companies will operate under the MedPharm moniker. Tergus CEO Michael Kane was named chief executive of MedPharm while Patrick Walsh will retain his title of MedPharm’s chairman, according to the press release.
“Pharma clients have been seeking a reliable,...
Today's Sponsors
Today's Sponsor